Gain on sale and valuation loss on investment securities recognized
First written in FY2021-Q3. 14 of 17 entries say "Advanced", first in FY2021. Latest entry: FY2026.
0 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「During the current consolidated fiscal year, the Company recognized impairment losses of ¥610.068 million on securities, all of which related to investment securities.」
For the full fiscal year, the Company recorded an impairment loss on investment securities of ¥610.068 million. As in the previous fiscal year, the impairment loss on investment securities was reflected in full-year profit or loss. - FY2026-H1AdvancedAnnual report
「Gain on sale of investment securities 3,936 Impairment loss on investment securities 76,999」
During the current interim consolidated accounting period, the Company recorded a gain on sale of investment securities of ¥3.936 million and an impairment loss on investment securities of ¥76.999 million. Both the gain on sale and the impairment loss were smaller than in the previous interim consolidated accounting period. - FY2025AdvancedAnnual report
「Gain on sale of investment securities 355,603 Impairment loss on investment securities 680,219」
For the current consolidated fiscal year, the Company recorded a gain on sale of investment securities of ¥355.603 million and an impairment loss of ¥680.219 million. Gains and losses from the sale and valuation of investment securities had a greater impact on full-year profit or loss than in the previous fiscal year. - FY2025-H1AdvancedAnnual report
「Proceeds from sale of investment securities 418,900 Impairment loss on investment securities 382,626」
During the current interim consolidated accounting period, the Company recorded proceeds from the sale of investment securities of ¥418.900 million and an impairment loss on investment securities of ¥382.626 million. - FY2024AdvancedAnnual report
「Gain on sale of investment securities - Impairment loss on investment securities 105,057」
For FY2024, the Company recorded an impairment loss on investment securities of ¥105.057 million. It also disclosed sales of other securities totaling ¥249.861 million and gains on sale of ¥89.845 million. - FY2024-Q3AdvancedAnnual report
「Impairment loss on investment securities 63,489」
During the current cumulative third-quarter consolidated period, the Company recorded an impairment loss on investment securities of ¥63.489 million. - FY2024-Q2AdvancedAnnual report
「Impairment loss on investment securities 55,729」
During the current cumulative second-quarter consolidated period, the Company recorded an impairment loss on investment securities of ¥55.729 million. - FY2023-Q3AdvancedAnnual report
「Gain on sale of shares of affiliates 76,459」
During the current cumulative third-quarter consolidated period, the Company recorded a gain on sale of shares of affiliates of ¥76.459 million. The impact of the sale related to the transfer of all shares of CONSUMER SEARCH HONG KONG LIMITED was reflected in profit or loss. - FY2023-Q2AdvancedAnnual report
「Gain on sale of investment securities 146,414」
During the cumulative second-quarter period, the Company recorded a gain on sale of investment securities of ¥146.414 million. - FY2023-Q1AdvancedAnnual report
「Gain on sale of investment securities 78,434」
During the current cumulative first-quarter consolidated period, the Company recorded a gain on sale of investment securities of ¥78.434 million. - FY2022AdvancedAnnual report
「Gain on sale of investment securities 284,788 Impairment loss on investment securities 332,991」
For the full fiscal year, the Company recorded a gain on sale of investment securities of ¥284.788 million and an impairment loss of ¥332.991 million, with the impact of the sale and valuation of investment securities reflected in the full-year results. - FY2022-Q3AdvancedAnnual report
「Gain on sale of investment securities 254,104 Impairment loss on investment securities 127,716」
During the cumulative third-quarter period, the Company recorded a gain on sale of investment securities of ¥254.104 million and an impairment loss on investment securities of ¥127.716 million. - FY2022-Q2AdvancedAnnual report
「Gain on sale of investment securities 254,104 Impairment loss on investment securities 125,206」
During the cumulative second-quarter period of the 50th fiscal year, the Company recorded a gain on sale of investment securities of ¥254.104 million and an impairment loss on investment securities of ¥125.206 million. - FY2021AdvancedAnnual report
「Gain on sale of investment securities 359,574 Impairment loss on investment securities 245,541」
For the full fiscal year, the Company recorded a gain on sale of investment securities of ¥359.574 million and an impairment loss of ¥245.541 million. - FY2021-Q3First statedAnnual report
「Gain on sale of investment securities 359,574 Impairment loss on investment securities 162,500」
During the cumulative third-quarter consolidated period, the Company recorded a gain on sale of investment securities of ¥359.574 million and an impairment loss on investment securities of ¥162.500 million.